BOSTON SCIENTIFIC CORPORATION
Clinical trial NCT05503173 updates: 1. completion date: 2026-05-01 → 2026-12-01 2. primary completion date: 2026-05-01 → 2026-12-01 3. enrollment: not set → 385 participants
Clinical trial NCT05503173 updates: 1. completion date: 2026-05-01 → 2026-12-01 2. primary completion date: 2026-05-01 → 2026-12-01 3. enrollment: not set → 385 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical